We boast a multimillion pound state-of-the-art positron emission tomography (PET) facility, which is the first of its kind in Wales.
We provide a clinical service to the Welsh NHS, a private patient service to most private healthcare providers, research scans for multi-centre and commercial trials and pre-clinical and radiochemistry research.
Our facilities are used to diagnose a range of diseases (particularly cancer) and monitor the progress of treatment and recovery. They also help streamline and enhance the discovery of new medicines.
Our facilities consist of:
- a cyclotron
- a good manufacturing practice (GMP) radiopharmaceutical production facility
- a GMP quality control (QC) laboratory with a wide range of analytical equipment.
About positron emission tomography
Positron emission tomography is a nuclear medicine, functional imaging technique that produces a three dimensional image of functional processes in the body.
A pharmaceutical tagged with a positron emitting radionuclide (radiopharmaceutical) is introduced into the body and the PET scanner detects the pairs of gamma rays emitted when the positron is emitted by the radionuclide.
The gamma rays are then used to generate a three dimensional functional image of the radiopharmaceutical concentration in the body. Anatomical information is obtained at the same time using a computed tomography (CT) scanner. Combining the functional PET image with the anatomical CT image produces a fused PET/CT image.
Our equipment enables us to diagnose a range of diseases and monitor the progress of treatment and recovery.